Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Roche Holdings ADR RHHBY

Healthcare
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue... see more

Recent & Breaking News (OTCQX:RHHBY)

FDA Accepts Application for Genentech's Port Delivery System With Ranibizumab (PDS) for Treatment of Wet Age-Related Macular Degeneration (AMD)

Business Wire June 24, 2021

Roche SARS-CoV-2 molecular test granted first FDA Emergency Use Authorization for PCR testing of both symptomatic and asymptomatic individuals at the point of care

PR Newswire June 18, 2021

Atea Pharmaceuticals Announces Achievement of AT-527 Development Milestone Under License Agreement with Roche

GlobeNewswire June 16, 2021

Genentech Announces Data at EHA2021 Reinforcing Efficacy of Venclexta Combinations in Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia

Business Wire June 11, 2021

New Genentech Data for Evrysdi (risdiplam) Show Improved Motor Function in Pre-Symptomatic Babies After One Year and Confirm Safety Profile in Previously Treated People With Spinal Muscular Atrophy (SMA)

Business Wire June 11, 2021

Roche's Accu-Chek® Inform II Hospital Blood Glucose System now approved by Health Canada for Intensive Care Use

Canada NewsWire June 9, 2021

Genentech Presents Latest Advances With Immunotherapies in Non-Hodgkin's Lymphoma

Business Wire June 4, 2021

Pivotal Phase III Data at ASCO Show Genentech's Tecentriq Helps Certain People With Early Lung Cancer Live Significantly Longer Without Their Disease Returning

Business Wire May 19, 2021

Roche Diagnostics Canada partners with Canadian Blood Services to include Elecsys® Anti-SARS-CoV-2-S and Elecsys® Anti-SARS-CoV-2 serology tests in the first Canadian COVID-19 seroprevalence study that includes the distinction between antibodies generated by COVID-19 vaccines and natural infection

Canada NewsWire May 18, 2021

Roche receives FDA authorisation for testing of asymptomatic people with the cobas SARS-CoV-2 Test to help control the spread of COVID-19

PR Newswire May 18, 2021

Genentech to Present Data From One of the Most Comprehensive Oncology Portfolios at the 2021 ASCO Annual Meeting Showcasing Advancements for People Living With Cancer

Business Wire May 11, 2021

FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approval of Genentech's Tecentriq for Previously Untreated Metastatic Bladder Cancer

Business Wire April 28, 2021

FDA Advisory Committee Votes in Favor of Maintaining Accelerated Approval of Genentech's Tecentriq for PD-L1-Positive, Metastatic Triple-Negative Breast Cancer

Business Wire April 27, 2021

 New Data for Genentech's Ocrevus (ocrelizumab) Reinforce Significant Benefit on Slowing Disease Progression in Relapsing and Primary Progressive Multiple Sclerosis

Business Wire April 16, 2021

Genentech's Evrysdi Continues to Improve Motor Function and Survival in Babies With Type 1 Spinal Muscular Atrophy (SMA)

Business Wire April 15, 2021

Spark Therapeutics Enters Collaboration with Senti Bio to Bolster Industry-Leading Gene Therapy Research Platform

GlobeNewswire April 13, 2021

Senti Bio Enters Collaboration with Spark Therapeutics to Develop Next-Generation Precision Gene Therapies

GlobeNewswire April 13, 2021

 FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications

Business Wire April 12, 2021

New Genentech Data at 2021 AAN Highlight Impact and Breadth of Expanding Neuroscience Portfolio

Business Wire April 8, 2021

New Roche's Elecsys® Anti-SARS-CoV-2-S serology test available in Canada to measure the level of SARS-CoV-2 antibodies: A major addition to Roche's innovative COVID-19 solutions

Canada NewsWire April 6, 2021